Scorpion Therapeutics logo

Scorpion Therapeutics Funding & Investors

Scorpion Therapeutics was founded to broaden the reach and impact of precision medicine to more people with cancer. The company is integrating cutting-edge technologies across target discovery, medicinal chemistry, and translational medicine to deliver Precision Oncology 2.0. Scorpion’s experienced leadership team is executing a fit-to-purpose model to efficiently unlock the next generation of precision oncology.

scorpiontx.com

Total Amount Raised: $420,000,000

Scorpion Therapeutics Funding Rounds

  • Series C

    $150,000,000

    Series C Investors

    Frazier Life Sciences Management
    Lightspeed Venture Partners
    Omega Fund Management
    OrbiMed Advisors
    Woodline Partners
    Abingworth
    Wellington Management
    Willett Advisors
    Vida Ventures
    Nextech Invest
    Casdin Capital
    Atlas Venture
    Logos Capital
    Fidelity Investments
    Surveyor Capital
    Boxer Capital
    EcoR1 Capital
    Invus Group
  • Series B

    $162,000,000

    Series B Investors

    Boxer Capital
    EcoR1 Capital
    Vida Ventures
    Abingworth
    Woodline Partners
    Atlas Venture
    Wellington Management
    Logos Capital
    Invus Group
    Janus Henderson Investors
    Omega Fund Management
    Nextech Invest
    OrbiMed Advisors
    Casdin Capital
    Surveyor Capital
  • Series A

    $108,000,000

    Series A Investors

    Atlas Venture
    Omega Fund Management
    Vida Ventures
    Abingworth
    Partners HealthCare Innovation
    Mass General Brigham
Funding info provided by Diffbot.